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Abstract
Background: To investigate the effects of combined corneal wavefront-guided transepithelial photorefractive
keratectomy (tPRK) and accelerated corneal collagen cross-linking (CXL) after intracorneal ring segment (ICRS)
implantation in patients with moderate keratoconus.
Methods: Medical records of 23 eyes of 23 patients undergoing combined tPRK and CXL after ICRS implantation
were retrospectively analyzed. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA),
manifest refraction spherical equivalent (MRSE), corneal indices based on Scheimpflug tomography, higher-order
aberrations (HOAs), and corneal biomechanical properties were evaluated before and after ICRS implantation, and at
1, 3, and 6 months after combined tPRK and CXL.
Results: There were significant improvements in final logMAR UDVA and logMAR CDVA, and reductions in sphere,
MRSE, and all corneal indices from baseline. Significant improvements in logMAR UDVA and reductions in sphere,
MRSE, maximal keratometry, keratometry at the apex, mean keratometry, and keratoconus index were noted after
ICRS implantation. After tPRK and CXL, significant improvements in logMAR UDVA and logMAR CDVA, and
reductions in cylinder and all corneal indices were observed. There were significant improvements in final root
mean square HOAs and coma aberrations from baseline, but no changes from baseline after ICRS implantation.
Significant reductions in final radius and deformation amplitude from baseline were noted.
Conclusions: Combined tPRK and accelerated CXL after ICRS implantation in moderate keratoconus appears to be
a safe and effective treatment, providing an improvement in visual acuity, corneal indices, and HOAs.
Trial registration: retrospectively registered (identification no. NCT03355430). Date registered: 28/11/2017.
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Background
Collagen cross-linking (CXL) is known to alter cor-
neal biomechanics and increase mechanical rigidity by
strengthening the corneal tissue, consequently result-
ing in significant increases in stiffness of the anterior
corneal stroma [1]. Patients with keratoconus, ectasia
after photorefractive surgery, corneal infections, and
chemical burns can benefit from CXL [2–7]. An
accelerated CXL protocol, involving application of a
higher-intensity light for a shorter period of time, has
been developed and is applicable in a variety of clin-
ical settings [8, 9]. Accelerated CXL could halt or
slow down the progression of keratoconus, and dem-
onstrates visual and keratometric outcomes compar-
able to those of conventional CXL [10–13]. Moreover,
the shortened treatment time is beneficial for patient
comfort and combination of the approach with other
therapies including transepithelial photorefractive
keratectomy (tPRK), laser in situ keratomileusis
(LASIK), or PRK and single intrastromal ring segment
implantation for keratoconus treatment [9, 14–16].
Visual rehabilitation has been accomplished through differ-
ent combinations of intracorneal ring segment (ICRS) im-
plantations, CXL, and/or photorefractive keratectomy (PRK)
for keratoconic patients. ICRS implantations act by flattening
the central cornea without affecting the corneal visual axis
[17, 18]. They have been reported to be effective in reducing
mean keratometry values, coma aberrations, and corneal
astigmatism [19–21]. Several studies have evaluated the ef-
fects of combined CXL and ICRS implantation in patients
with keratoconus, and have shown overall additive effects on
visual acuity and keratometry values [22, 23]. Combined
PRK and CXL have also been used for the treatment of kera-
toconus [24–27]. A study investigating the effect of
topography-guided PRK and CXL after ICRS implantation
in patients with low to moderate keratoconus has demon-
strated that uncorrected distance visual acuity (UDVA),
corrected distance visual acuity (CDVA), keratometry values,
and coma aberrations were significantly improved at
6-months postoperatively [28]. Additionally, Coskunseven et
al. have reported that, in patients with progressive keratoco-
nus, topography-guided tPRK, after ICRS implantation and
followed by CXL, resulted in an improvement in logMAR
UDVA, logMAR CDVA, manifest refraction spherical
equivalent (MRSE), and mean steep and flat keratometry
values [29]. Recently, Zeraid et al. have shown similar results
for logMAR UDVA and keratometry values, but demon-
strated no significant reduction in coma aberrations after
ICRS implantation followed by same-day topography-guided
PRK and CXL [30]. Another study has reported that the
combination of accelerated CXL and same-day transepithe-
lial phototherapeutic keratectomy and single inferior ICRS is
as effective as the combined treatment, using standard CXL,
in terms of visual and topographical outcomes [9].
Changes in a variety of corneal biomechanical prop-
erties after PRK, LASIK, small incision lenticule
extraction, and CXL can be evaluated using the dy-
namic Scheimpflug analyzer (corneal visualization
Scheimpflug technology [Corvis ST], OCULUS,
Wetzlar, Germany) [31–34]. This instrument captures
the dynamic process of corneal deformation caused
by an air puff, using an ultra-high-speed Scheimpflug
camera that acquires up to 4330 images per second
[34]. Furthermore, recent studies demonstrated that
the dynamic Scheimpflug analyzer can be used for
differentiating normal eyes from those with keratoco-
nus [35–37].
Because of the positive effects achieved by combina-
tions of these surgical modalities in the treatment of
keratoconus, we hypothesized that corneal wavefront-
guided tPRK and high-fluence accelerated corneal
CXL after ICRS implantation would also show clinical
improvement in patients with moderate keratoconus.
Additionally, the changes in corneal biomechanical
properties during combined corneal wavefront-guided
tPRK and corneal CXL after ICRS implantation are
not yet fully understood. Therefore, the aim of this
study was to evaluate the efficacy, safety, higher-order
aberrations (HOAs), and corneal biomechanical prop-
erties in patients with moderate keratoconus after
ICRS implantation, followed by combined corneal
wavefront-guided tPRK and corneal CXL.
Methods
We performed a retrospective, interventional case series
of patients with moderate keratoconus who underwent
combined corneal wavefront-guided tPRK and high-
fluence accelerated CXL at least 1 month after ICRS im-
plantation from January 2010 to December 2015 at the
Eyereum Eye Clinic (Seoul, South Korea). The study ad-
hered to the tenets of the Declaration of Helsinki and
followed good clinical practices with the approval of the
Institutional Review Board of Yonsei University College of
Medicine (Seoul, South Korea). All patients provided in-
formed written consent for their medical information to
be included in analysis and for publication. We retrospect-
ively reviewed the medical records of 23 eyes of 23 pa-
tients that met the inclusion and exclusion criteria, as
defined below.
Combined corneal wavefront-guided tPRK and acceler-
ated CXL after ICRS implantation were performed if a
patient was intolerant to contact lenses, had moderate
keratoconus without apical scarring, and if progression
had been noted over the previous 6 months. All included
patients underwent combined corneal wavefront-guided
tPRK and CXL at least 1 month (average 2.7 ±
1.1 months; range 1 to 4 months) after ICRS implant-
ation. We excluded patients with central or para-central
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corneal scarring, central pachymetry <400 μm, corneal
endothelial cell density of less than 2000 cells/mm2,
systemic autoimmune disease, a history of herpetic
corneal disease, pregnancy, lactation, or severe dry eye
syndrome.
Grading of keratoconus was based on the Amsler
−Krumeich classification [38]. Progression was defined
as one or more of the following changes over a period of
6 months: an increase of ≥1.00 diopter (D) in maximal
keratometry values, an increase of ≥1.00 D in manifest
cylinder, and an increase of ≥0.50 D in MRSE.
Examinations and measurements
Before ICRS implantation (baseline) and after ICRS im-
plantation (before combined tPRK and CXL), and at 1, 3,
and 6 months after combined tPRK and CXL, all patients
underwent complete ophthalmic examinations, which in-
cluded examinations for UDVA and CDVA with a Snellen
chart (converted to the logMAR scale for statistical ana-
lysis), manifest refraction (MR), and autorefraction using
the ARK-530A (NCT Nidek Co., Ltd., Aichi, Japan). The
safety index was calculated from the final postoperative
CDVA/baseline CDVA ratio (in logMAR). The efficacy
index was calculated as the final postoperative UDVA/
baseline CDVA ratio (in logMAR). Multiple corneal indices
were measured at the 8-mm zone using the Scheimpflug
tomography system (Pentacam HR; OCULUS).
For measuring changes in corneal aberrations, includ-
ing HOAs, coma, and spherical aberrations, corneal
wavefront analysis was implemented using corneal topo-
graphic data obtained with a Keratron Scout topog-
rapher (Optikon, Rome, Italy). Root mean square (RMS)
values of the corneal HOAs, with analysis up to the 7th
order by expanding the set of Zernike polynomials, were
calculated.
Corneal biomechanical properties were measured using
the dynamic Scheimpflug analyzer at approximately the
same time of day. The dynamic Scheimpflug analyzer
automatically calculated corneal deformation amplitude,
radius values, and maximal concave power when the cor-
nea is deformed to its greatest curvature by the air puff.
The deformation amplitude is defined as the maximum
amplitude when the cornea is deformed to its greatest
concave curvature and is influenced by corneal stiffness
[39]. The radius values represent the central concave
curvature at the highest concavity (depressed to the high-
est concavity), while maximal concave power is the inverse
radius of the curvature at the highest concavity.
Surgical technique
As a first step, all patients underwent femtosecond laser-
enabled (IntraLase FS; Abbott Medical Optics, Abbott
Park, IL, USA) placement of ICRS (Keraring; Mediphacos,
Belo Horizonte, Brazil). Segment sizes were determined
according to the nomogram provided by the manufac-
turer. The depth of the ring channels was set at 75−80%
of the thinnest pachymetry reading. After surgery, a
bandage contact lens (Acuvue Oasys; Johnson & Johnson
Vision Care, Inc., Jacksonville, FL, USA) was placed to be
removed the next day. Postoperative medication included
topical moxifloxacin 0.5% (Vigamox; Alcon Laboratories,
Fort Worth, TX, USA) and fluorometholone 0.1% (Santen
Pharmaceutical, Osaka, Japan).
After at least 1 month (average 2.7 ± 1.1 months; range
1 to 4 months), all patients were scheduled for combined
corneal wavefront-guided tPRK and accelerated CXL
treatment. tPRK between the corneal ring segments was
performed using an excimer laser (Amaris 1050 Excimer
Laser platform; Schwind eye-tech-solutions GmbH and
Co KG, Kleinostheim, Germany). The ablation profile
was planned using the integrated Optimized Refractive
Keratectomy-Custom Ablation Manager software (ver-
sion 5.1; Schwind eye-tech-solutions GmbH and Co
KG). Using this software, ablation was planned based on
clinical parameters, including manifest refraction, pachy-
metry, and corneal wavefront data (up to the 7th order)
and topography obtained with the Keratron Scout. The
optic zone area of tPRK was 5.8 mm−7.5 mm, and the
total ablation zone was up to 8.6 mm.
0.1% riboflavin with hydroxypropyl methylcellulose
(Vibex Rapid; Avedro Inc., Waltham, MA, USA) was
soaked onto the corneal surface for 10 min immediately
after excimer laser ablation. Additional riboflavin solu-
tion was added as needed during the soaking process
after which was irrigated with 60 cc of chilled balanced
saline solution at completion of soaking. UVA exposure
(wavelength: 365 nm) was performed with the KXL
system (Avedro Inc., USA) which was set to provide a
uniform circular diameter of 9.0 mm of irradiation for
360 s at a power of 15 mW/cm2 (total dose: 5.4 J/cm2)
in a 1:1 pulsatile fashion. The cornea was kept wet at
30-s intervals with additional BSS during the irradiation
process.
At the end of the surgery, topical levofloxacin 0.5%
(Cravit; Santen Pharmaceutical) and fluorometholone
0.1% were administered, a bandage contact lens was
placed, and the eye was examined under the slit-lamp.
After surgery, topical levofloxacin 0.5% and fluoro-
metholone 0.1% were applied 4 times daily, for 1 month.
The dosage was gradually reduced over 3 months.
Statistical analysis
Results are expressed as mean ± standard deviation. The
Shapiro-Wilk test was used to confirm the normality of
data. We performed repeated measures one-way analysis
of variance (ANOVA) with Bonferroni-adjusted post-hoc
comparison to evaluate the differences between parame-
ters in each follow-up period. All statistical analyses were
Lee et al. BMC Ophthalmology  (2017) 17:270 Page 3 of 14
performed using SPSS software version 20.0 (IBM,
Armonk, NY, USA). Statistical significance was defined as
P < .05.
Results
This study included 23 eyes of 23 patients (6 women, 17
men). The mean patient age was 27.1 ± 4.4 years (range:
20−38 years). Table 1 summarizes the baseline patient
demographics and clinical characteristics. All surgical
procedures were uneventful and no postoperative com-
plications were observed during the observation period.
Tables 2 and 3 summarize the postoperative visual acu-
ity, refractive outcomes, and corneal indices before ICRS
implantation (baseline), before and at 1, 3, and 6 months
after combined tPRK and CXL. After ICRS implantation,
there were significant improvements in logMAR UDVA
(P < .001) and reduction in sphere (MR) (P = .002),
MRSE (P = .002), maximal keratometry values (Kmax)
(P = .001), keratometry values at the apex (Apex K) (P
< .001), mean keratometry values (mean K) (P = .001),
and keratoconus index (KI) (P = .002) (Fig. 1). After
tPRK and CXL, there were significant improvements in
logMAR UDVA (P < .001) and logMAR CDVA (P = .024),
and reduction in cylinder (P = .020) and all corneal indices
(all P < .001) as compared with these values before tPRK
and CXL (Fig. 1). There were significant improvements in
final logMAR UDVA and logMAR CDVA (all P < .001),
and reductions in sphere (P = .046), MRSE (P = .005), and
all corneal indices from baseline (all P < .001) (Figs. 1, 2
and 3). The safety and efficacy indexes were 0.26 ± 0.27
and 0.89 ± 1.01, respectively. When comparing the
differences among 1, 3, and 6 months after combined
tPRK and CXL to investigate the effect of different recov-
ery time of visual acuity, logMAR CDVA showed signifi-
cant improvement between 1 month and 6 months after
tPRK-CXL (P = .002). The cylinder significantly decreased
at 6 months after tPRK-CXL, when compared with
1 month after tPRK-CXL (P = .023). After ICRS implant-
ation, there was no significant reduction in any corneal
aberrations. However, after tPRK and CXL, there were
statistically significant reductions in RMS HOAs and
coma aberrations (both P < .001) as compared with these
values before tPRK and CXL. There were also significant
improvements in final RMS HOAs and coma aberration
values from baseline (both P < .001; Table 4, Fig. 1). When
comparing the differences among 1, 3, and 6 months after
combined tPRK and CXL to investigate the effect of
different recovery time of corneal HOAs, the RMS
HOAs significantly decreased during the follow up
period (P = .025 for 1 month vs 3 months, P < .001 for
1 month vs 6 months, and P < .001 for 3 month vs
6 months; Table 4). The spherical aberration showed
significant difference between 1 month and 6 months
after tPRK-CXL (P = .008).
Preoperative and postoperative corneal biomechan-
ical properties, as measured with the dynamic
Scheimpflug analyzer, are shown in Table 5. There
were significant reductions in final radius (P = .012)
and deformation amplitude (P = .012), and an increase
in final maximal concave power (P = .005) from base-
line. After tPRK and CXL, there was a statistically
significant decrease in deformation amplitude (P
= .042), as compared with these values before tPRK
and CXL, without changes after ICRS implantation
from baseline (Table 5).
Discussion
In the present study, we investigated the effects of com-
bined corneal wavefront-guided tPRK and accelerated
corneal CXL after ICRS implantation on the visual
acuity, refractive outcomes, corneal indices, HOAs, and
corneal biomechanical properties in patients with moder-
ate keratoconus. We demonstrated that combined tPRK
and CXL after ICRS implantation is beneficial for visual
rehabilitation in moderate progressive keratoconus.
As a progressive non-inflammatory ectatic disease,
keratoconus involves changes in corneal collagen
structure and the intercellular matrix, as well as apop-
tosis and necrosis of keratocytes [40–42]. CXL stabilizes
Table 1 Characteristics of eyes undergoing combined corneal
wavefront-guided transepithelial photorefractive keratectomy
and accelerated corneal collagen cross-linking after intracorneal
ring segment implantation in patients with moderate
keratoconus
Characteristics 23 eyes of 23 patients
Age, years old 27.1 ± 4.4 (20 to 38)
Sex (% women) 26%
Refractive errors (D)
Sphere −1.41 ± 2.30 (−7.50 to 2.75)
Cylinder −1.83 ± 1.37 (−5.00 to 0.00)
MRSE −2.33 ± 2.22 (−8.00 to 1.25)
Keratometric value
Flat K 46.5 ± 3.2 (41.3 to 56.3)
Steep K 48.0 ± 3.6 (43.3 to 57.8)
Mean K 47.2 ± 3.1 (42.5 to 55.0)
logMAR UDVA 0.85 ± 0.27 (0.30 to 1.30)
logMAR CDVA 0.25 ± 0.18 (0.10 to 0.70)
Optical zone (mm) 6.84 ± 0.36 (6.26 to 7.50)
Total ablation zone (mm) 7.88 ± 0.48 (6.89 to 8.59)
Ablation depth (μM) 34.17 ± 11.60 (14.23 to 54.85)
CCT (μM) 463.9 ± 30.5 (415.0 to 541.0)
Results are expressed as means ± standard deviation (range)
D diopters, MRSE manifest refraction spherical equivalent, K keratometry, UDVA
uncorrected distance visual acuity, CDVA corrected distance visual acuity, CCT
central corneal thickness
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stromal collagen fibers and hardens the structure of the
corneal stroma by inducing formation of additional
covalent connections between collagen fibers and other
molecules. CXL is also reported to result in topograph-
ical flattening of a mean of 2.00 D [43]. The recent
introduction of prophylactic CXL application, simultan-
eously performed with LASIK, aims at strengthening the
cornea, particularly in highly myopic eyes with a thin
residual stroma [44, 45]. Given the flattening and strength-
ening effects of concurrent prophylactic CXL, CXL halts
the progression of keratoconus and stabilizes the cornea for
an extended period of time [3, 4, 7, 9, 12, 46].
There have been multiple reports on the combin-
ation of ICRS implantation and prophylactic CXL in
patients with keratoconus. For example, Chan et al.
demonstrated an additive effect of combination of
ICRS implantation and CXL on maximal keratometry
values and cylindrical error [47]. Improvement in vis-
ual acuity and keratometry values after combination
of ICRS implantation and prophylactic CXL has also
been reported [23]. Moreover, El-Raggal reported that
combining ICRS implantation and CXL in a single,
same-day session more effectively reduces keratometry
values than consecutive ICRS implantation and CXL,
as determined at 6 months, under the assumption
that the newly dissected corneal channel created by
femtosecond laser may result in more riboflavin pool-
ing and exaggerating the flattening effect of CXL [48].
Combination of PRK, ICRS implantations, and CXL is
also known to have an additive effect on visual acuity
and keratometry values [9, 28, 29] In our study, we
performed combined tPRK and CXL after ICRS
implantation in patients with moderate keratoconus.
Before employing the combined tPRK and CXL, we
performed ICRS implantation, which is known to flat-
ten the conic cornea and shift the decentralized cor-
neal apex more centrally. ICRS implantation is
thought to allow implementation of tPRK with min-
imal tissue ablation. We based on previous reports
suggested that high-fluence accelerated prophylactic
CXL, performed in combination with tPRK, could not
only halt the progression of keratoconus, but also
correct refractive errors and reduce HOAs in eyes
undergoing ICRS implantation.
In the present study, after ICRS implantation, there
were significant improvements in logMAR UDVA and
reduction in MRSE, Kmax, Apex K, mean K, and KI
from baseline. These results agreed with a study
reporting increased UDVA and CDVA and decreased
spherical equivalent and mean keratometry values
after ICRS implantation, before CXL [48]. We also
demonstrated that, after combined tPRK and CXL,
there were significant improvements in logMAR
UDVA and logMAR CDVA, and reduction in all cor-
neal indices, as compared with before tPRK and CXL.
These effects were also shown in an earlier study that
demonstrated an additive effect of CXL in terms of an in-
crease in UDVA and decrease in keratometry values [48].
Fig. 1 Changes in refractive outcomes, maximal keratometry, and corneal higher-ordrer aberrations in patients with moderate keratoconus who
underwent combined corneal wavefront-guided transepithelial photorefractive keratectomy and high-fluence accelerated corneal collagen cross-
linking after intracorneal ring segment implantation. Preop = preoperative; ICRS = intracorneal ring segment implantation; tPRK-CXL = corneal
wavefront-guided transepithelial photorefractive keratectomy and corneal collagen cross-linking; MRSE =manifest refraction spherical equivalent;
RMS HOAs = root mean square higher-order aberrations. Error bars represent standard error of the mean (*P < .05, **P < .01, ***P < .001)
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All final parameters, except cylindrical error, were signifi-
cantly improved from baseline, which agreed with other
reports [28, 49]. In terms of safety and efficacy, our results
demonstrated better outcomes compared to those ob-
tained in previous studies [28].
In the present study, we demonstrated a significant re-
duction in final RMS HOAs and coma aberrations as com-
pared with values at baseline and before tPRK and CXL.
We reported an improvement in logMAR UDVA attribut-
able to lower order aberration correction by tPRK, and
Fig. 2 In this patient with moderate keratoconus, combined corneal wavefront-guided transepithelial photorefractive keratectomy (tPRK) and
high-fluence accelerated corneal collagen cross-linking (CXL) after intracorneal ring segment (ICRS) implantation achieved a progressive flattening
of the cone, as compared to baseline (a). Representative corneal topography changes after ICRS implantation (b), and at 3 and 6 months after
combined tPRK and accelerated CXL (c and d)
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improvement in logMAR CDVA with concomitant de-
crease in corneal HOAs [50, 51]. The main debilitating vis-
ual symptoms experienced by patients with keratoconus
are reported to be from the predominant coma aberrations,
as well as astigmatism and vertical trefoil [20, 52–54]. A re-
cent study showed that logMAR UDVA and keratometry
values improved, whereas coma aberrations did not change,
after ICRS implantation followed by same-day topography-
guided PRK and CXL [30]. On the other hand, in another
study investigating the effect of topography-guided PRK
and CXL after ICRS implantation in patients with low to
moderate keratoconus, final coma aberrations were signifi-
cantly decreased when compared with from baseline and
after ICRS implantation [28]. This was in accordance with
our findings. Moreover, we observed a greater reduction in
coma aberrations than those previously reported (1.78 μm
versus 0.26 μm) [28]. On average, 72.1% of preoperative
coma aberrations were reduced at final follow up (from
2.47 μm to 0.69 μm) with RMS HOAs reduced by 62.3%
(2.87 μm to 1.08 μm). This larger reduction may be
attributable to the transepithelial ablation profile. A fixed
55-μm tPRK ablation in our combinatory approach may as-
sist the correction of coma aberrations originating mainly
in the area of the cone where the epithelium is thinnest
[55]. In keratoconic eyes, spherical aberrations have been
observed to become more negative as the cone bulges more
anteriorly [52]. In our study, there was a trend for spherical
aberrations to shift to a less hyperprolate corneal shape
(0.15 μm to 0.30 μm), albeit not reaching statistical signifi-
cance, in accordance with decrease in Kmax. This may be
due to the limited amount of ablation depth used in the
present study that was insufficient to change corneal shape
over a larger area.
In terms of corneal biomechanics, our results showed
that final deformation amplitude decreased significantly
as compared with that at baseline and before tPRK and
CXL. Considering that thinner corneas tend to demon-
strate higher deformation amplitudes and that this
parameter reflects corneal stiffness, high-fluence acceler-
ated CXL appears to be able to strengthen the cornea in
Fig. 3 Difference map in patient with moderate keratoconus who underwent combined corneal wavefront-guided transepithelial photorefractive
keratectomy (tPRK) and high-fluence accelerated corneal collagen cross-linking (CXL) after intracorneal ring segment (ICRS) implantation. Although
the majority of curvature changes occur by combined tPRK and CXL, ICRS implantation also serves to provide 20–30% additive effects. (a) axial
map (difference), left; after ICRS implantation alone versus before ICRS implantation (baseline), right; 6 months after tPRK and CXL versus after ICRS
implantation alone, (b) tangential map (difference), left; after ICRS implantation alone versus before ICRS implantation (baseline), right; 6 months
after tPRK and CXL versus after ICRS implantation alone
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keratoconus [39]. Moreover, the deformation amplitude
is a parameter that can be measured with high repeat-
ability and reproducibility when evaluating corneal
biomechanics [39, 56]. On the other hand, final radius
values significantly decreased as compared with values at
baseline. Considering that the radius represents the central
concave curvature at the highest concavity, these results
contradict changes in deformation amplitude. Thus, the re-
sults obtained from the dynamic Scheimpflug analyzer in
keratoconic corneas should be interpreted with caution.
Moreover, associations between corneal biomechanical
properties and corneal thickness or intraocular pressure
could affect measurements of corneal biomechanics.
Furthermore, more sensitive means of quantifying cor-
neal biomechanics or improvements in computation of
relevant parameters are essential when using the dynamic
Scheimpflug analyzer in keratoconic eyes.
The present study had several limitations, including its
retrospective design. Other possible limitations of this
study were the relatively small sample size and the lack
of a control group. A prospective, controlled long-term,
comparative paired-eye study should be performed to
validate the current results.
Conclusions
A combination of corneal wavefront-guided tPRK and ac-
celerated corneal CXL after ICRS implantation is an ef-
fective and safe option for correcting mild refractive
errors and improving visual acuity, corneal indices, and
HOAs in patients with moderate progressive keratoconus.
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